1. Home
  2. IRTC vs RXRX Comparison

IRTC vs RXRX Comparison

Compare IRTC & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRTC
  • RXRX
  • Stock Information
  • Founded
  • IRTC 2006
  • RXRX 2013
  • Country
  • IRTC United States
  • RXRX United States
  • Employees
  • IRTC N/A
  • RXRX N/A
  • Industry
  • IRTC Medical/Dental Instruments
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRTC Health Care
  • RXRX Health Care
  • Exchange
  • IRTC Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • IRTC 3.1B
  • RXRX 2.6B
  • IPO Year
  • IRTC 2016
  • RXRX 2021
  • Fundamental
  • Price
  • IRTC $100.96
  • RXRX $5.50
  • Analyst Decision
  • IRTC Strong Buy
  • RXRX Buy
  • Analyst Count
  • IRTC 10
  • RXRX 5
  • Target Price
  • IRTC $120.20
  • RXRX $8.20
  • AVG Volume (30 Days)
  • IRTC 365.8K
  • RXRX 23.6M
  • Earning Date
  • IRTC 05-01-2025
  • RXRX 05-08-2025
  • Dividend Yield
  • IRTC N/A
  • RXRX N/A
  • EPS Growth
  • IRTC N/A
  • RXRX N/A
  • EPS
  • IRTC N/A
  • RXRX N/A
  • Revenue
  • IRTC $591,839,000.00
  • RXRX $58,839,000.00
  • Revenue This Year
  • IRTC $17.46
  • RXRX $57.30
  • Revenue Next Year
  • IRTC $16.93
  • RXRX $47.96
  • P/E Ratio
  • IRTC N/A
  • RXRX N/A
  • Revenue Growth
  • IRTC 20.13
  • RXRX 32.00
  • 52 Week Low
  • IRTC $55.92
  • RXRX $3.79
  • 52 Week High
  • IRTC $128.52
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • IRTC 46.56
  • RXRX 48.15
  • Support Level
  • IRTC $98.41
  • RXRX $5.14
  • Resistance Level
  • IRTC $104.12
  • RXRX $6.00
  • Average True Range (ATR)
  • IRTC 6.10
  • RXRX 0.58
  • MACD
  • IRTC -0.15
  • RXRX 0.15
  • Stochastic Oscillator
  • IRTC 50.18
  • RXRX 77.38

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: